During this EOS webinar, meeting will cover:
• Eosinophils as actionable biomarkers and predictors of risk
• Strategies to achieve sustained SEA control and facilitate steroid reduction
• Clinical evidence for targeting eosinophils in systemic eosinophil-driven diseases
• The implementation of aggressive steroid reduction strategies in eosinophil-driven diseases